Cellectar Biosciences Files 8-K on Operations and Financials
Ticker: CLRB · Form: 8-K · Filed: May 13, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 8-K |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, disclosure
TL;DR
Cellectar Biosciences dropped an 8-K on May 13th covering financials and operations. Check it out.
AI Summary
Cellectar Biosciences, Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. The filing details the company's status as a Delaware corporation with its principal executive offices located in Florham Park, NJ.
Why It Matters
This 8-K filing provides an update on Cellectar Biosciences' operational and financial status, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of operational and financial information, not indicating any immediate or significant new risks.
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- May 13, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Florham Park, NJ (location) — Address of principal executive offices
- NOVELOS THERAPEUTICS, INC. (company) — Former company name
- COMMON HORIZONS INC (company) — Former company name
FAQ
What specific financial information is being reported in this 8-K?
The 8-K indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific details of these are not provided in the header.
When was the earliest event reported in this filing?
The earliest event reported was on May 13, 2025.
What is Cellectar Biosciences, Inc.'s state of incorporation?
Cellectar Biosciences, Inc. is incorporated in Delaware.
Where are Cellectar Biosciences, Inc.'s principal executive offices located?
The principal executive offices are located at 100 Campus Drive, Florham Park, NJ, 07932.
Has Cellectar Biosciences, Inc. operated under any former names?
Yes, the company previously operated under the names NOVELOS THERAPEUTICS, INC. and COMMON HORIZONS INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 13, 2025 regarding Cellectar Biosciences, Inc. (CLRB).